PDF

T/GDACM 0127-2024 Active

T/GDACM 0127-2024 Chinese medicine technical operation specification: Three-step sequential therapy for rheumatic and pain disorders

Available format(s)
PDF
Language(s)
Chinese
Publish Date
2024-01-18

Abstract

Main technical content: The "Rheumatism and Pain Triple Sequential Therapy" is a systematic comprehensive treatment technique for rheumatism and pain-related diseases, which was researched and summarized by clinicians in practice. The clinical application of the Rheumatism and Pain Triple Sequential Therapy covers a wide range of departments, diseases, regions, and patient groups. To clarify the clinical application methods of the Rheumatism and Pain Triple Sequential Therapy and improve the safety and effectiveness of medication, this project, based on a comprehensive search, selection, and synthesis of 474 published research papers on the Rheumatism and Pain Triple Sequential Therapy, and referring to the survey results of 128 doctors and 6,000 patients in China, combined with the clinical experience of the Expert Group on Technical Operation Standards of Traditional Chinese Medicine, has formulated this Technical Operation Standard of Traditional Chinese Medicine, providing a reference for clinicians to rationally use the Rheumatism and Pain Triple Sequential Therapy. This document stipulates the clinical application scope, operation methods, safety, and principles of adverse reaction prevention and treatment of the Rheumatism and Pain Triple Sequential Therapy. This document is applicable to clinical departments such as orthopedics, rheumatology, pain medicine, and rehabilitation, and the users are doctors who apply the Rheumatism and Pain Triple Sequential Therapy to treat rheumatism and pain-related diseases.

General Product Information

Document Type Group standards
Standard Status Active
Standard Code T/GDACM 0127-2024
ICS Integrated medical science and healthcare devices
Implement Date 2024-01-18
Price $ 20.00
Subtotal $ 20.00
Tax $ 0.00
Order Total (incl. tax) $ 20.00

Log In

Contact Us